As of 2024-12-14, the Fair Value of Gemini Therapeutics Inc (GMTX) is - USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.35 USD, the upside of Gemini Therapeutics Inc is -100.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -71.87 | -46.83 | - | - | -59.35 | |
| YoY growth | -8,745.42% | 34.84% | - | - | -4,355.29% | |
| Market Cap (mil) | 58.49 |
| P/E | |
| Forward P/E |
| EPS | |
| Avg earnings growth rate | -4,355.29% |
| TTM earnings | -46.83 |